Many people have pursued a Granuflo lawsuit on the heels of a recall that took this product off the market. The recall was implemented due to a number of reported dangers associated with Granuflo and Naturalyte. These are chemicals used in kidney dialysis. These drugs became highly popular in the treatment of kidney failure. However, a number of potentially harmful side effects began to emerge that medical authorities suspected were linked to these chemicals. In 2010, the manufacturer of these drugs, Fresenius Medical Care (FMC), reported 941 cases of cardiac arrests that were classified as side effects to these drugs.
With such clear reporting, many people have wondered what lead to the Granuflo lawsuits against FMC. The liability arose over the way the information was reported. The New York Times ran a story on a memo published by FMC in November of 2011. This memo stated identified cardiac arrest as a side effect of the drug. However, while the doctors who worked at the manufacturer’s dialysis centers were warned about the dangers of incorrect usage, other centers did not receive clear and timely warning. It was not until March of 2012, when the FDA published an anonymous copy of FMC’s memo that many doctors learned of these side effects for the first time.
Due to what the legal profession classifies as “failure to warn,” it is conceivable that lives could have been saved if the information had been expeditiously distributed to all dialysis centers and not just those owned by the manufacturer. The elevated bicarbonate levels caused by this chemical may very well have caused a number of heart attacks and other health problems to be prevented. Persons who have undergone treatment using this drug and have suffered specific side effects linked to its usage may be able to obtain compensation through a Granuflo lawsuit.
Specific symptoms include cardiopulmonary arrest, death during dialysis, heart attack during dialysis, and cardiac arrhythmia. Other symptoms and/or conditions include low blood pressure, stroke, and metabolic alkalosis. The impact of these side effects has far reaching consequences. When one considers that there are over 5700 dialysis centers in the nation, and almost half a million patients undergoing treatment in these centers, it becomes readily apparent why many individuals have chosen to pursue a Granuflo lawsuit. Granuflo and Naturalyte are both pumped through the blood during many dialysis treatments. Improper amounts of the drug have been linked to increased and/or more severe side effects, making dosage issues another element to consider in addition to the nature of the chemicals themselves.
If a dialysis patient has suffered from any of the above conditions, or has a loved one who has suffered from them, he or she may want to consider consulting with an attorney who is qualified to handle a Granuflo lawsuit. There may also be compensation for those who have lost loved ones to cardiac arrest or stroke that could have been caused by these substances. Contacting an attorney for a consultation would be the first step for those who desire compensation for these incidents.